Characterization of porcine tumor necrosis factor receptor 2: Implications for xenotransplantation

被引:5
|
作者
Costa, C.
Casinghino, S. R.
Fodor, W. L.
机构
[1] Hosp Llobregat, Hosp Duran & Reynals, Inst DInvest Biomed & Bellvitge IDIBELL, Barcelona 08907, Spain
[2] Alexion Pharmaceut Inc, Dept Mol Sci, Cheshire, CT USA
[3] Hosp Llobregat, Inst Invest Biomed & Bellvitge, Barcelona, Spain
[4] Univ Connecticut, Dept Mol & Cellular Biol, CT Ctr Regenerat Biol, Storrs, CT USA
关键词
D O I
10.1016/j.transproceed.2007.07.077
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Clinical solid organ xenotransplantation is precluded by the strong immune response that results in rejection of pig xenografts in primate models. Innate immunity seems to play a major role in this process. In particular, tumor necrosis factor (TNF), produced by natural killer cells and macrophages, contributes to xenograft rejection by promoting endothelial cell activation and the recruitment of inflammatory cells. To further elucidate its molecular mechanism, we cloned the full-length cDNA of porcine TNF-Receptor 2 (pTNFR2, p75) by reverse transcriptase polymerase chain reaction (PCR) of total RNA isolated from porcine peripheral blood mononuclear cells. To this end, we used degenerate primers based on the sequences of the mouse, rat, and human homologues. Two PCR fragments were obtained that contained the pTNFR2 sequence, but differed in size. The shorter clones lacked the sequence corresponding to exon 4 by homology but identical for the rest, suggesting there is an alternative spliced mRNA variant of the porcine receptor. The predicted protein sequence (461 amino acids, containing exon 4) exhibited 72.5% identity to the human TNFR2 and 58.7% to the mouse molecule. By predicted protein sequence analysis, we determined that it comprised the four TNFR cysteine-rich repeats conserved between species. However, the molecule missing exon 4 lacks one cysteine-rich repeat. To assess function, we produced two recombinant proteins containing the extracellular domain of each pTNFR2 variant fused to the Fc portion of human IgG1. Next, we examined their ability to inhibit human TNF-mediated activation of porcine aortic endothelial cells. The addition of the whole pTNFR2 fusion protein to the TNF treatment blocked the up-regulation of activation markers. However, the fusion protein lacking exon 4 failed to effectively counteract TNF effects. These two pTNFR2 isoforms may play differential roles in the process of xenograft rejection.
引用
收藏
页码:2443 / 2446
页数:4
相关论文
共 50 条
  • [1] Implications for xenotransplantation of a soluble variant of porcine tumor necrosis factor receptor 2
    Uribe-Herranz, Mireia
    Bosch, Laia
    Costa, Cristina
    XENOTRANSPLANTATION, 2009, 16 (05) : 389 - 389
  • [2] Characterization of putative regulatory isoforms of porcine tumor necrosis factor receptor 2 in endothelial cells
    Uribe-Herranz, Mireia
    Kuguel, Sebastian G.
    Casos, Kelly
    Costa, Cristina
    XENOTRANSPLANTATION, 2020, 27 (06)
  • [3] Analyses of porcine tumor necrosis factor receptor 2 expressed in endothelium
    Casos, Kelly
    Kuguel, Sebastian G.
    Uribe-Herranz, Mireia
    Costa, Cristina
    XENOTRANSPLANTATION, 2019, 26 (05)
  • [4] Molecular cloning of porcine (Sus scrofa) tumor necrosis factor receptor 2
    Cheng, Yuan
    Maeda, Akihisa
    Goto, Yasufumi
    Matsuda-Minehata, Fuko
    Manabe, Noboru
    JOURNAL OF REPRODUCTION AND DEVELOPMENT, 2007, 53 (06): : 1291 - 1297
  • [5] Structural and Expression Analyses of Porcine Tumor Necrosis Factor Receptor 2 Variants
    Uribe-Herranz, Mireia
    Kuguel, Sebastian G.
    Costa, Cristina
    TRANSPLANTATION, 2018, 102 : S733 - S733
  • [6] Clinical implications of tumor necrosis factor receptor 2 in breast cancer
    Yang, Fuqian
    Zhao, Zhonghua
    Zhao, Nana
    ONCOLOGY LETTERS, 2017, 14 (02) : 2393 - 2398
  • [7] Identification of soluble and membrane-bound isoforms of porcine tumor necrosis factor receptor 2
    Uribe-Herranz, Mireia
    Casinghino, Sandra R.
    Bosch-Presegue, Laia
    Fodor, William L.
    Costa, Cristina
    XENOTRANSPLANTATION, 2011, 18 (02) : 131 - 146
  • [8] Tumor necrosis factor alpha improves glucose homeostasis in diabetic mice independent with tumor necrosis factor receptor 1 and tumor necrosis factor receptor 2
    Wu, Shanshan
    Dong, Kai
    Wang, Jiajia
    Bi, Yaxin
    ENDOCRINE JOURNAL, 2018, 65 (06) : 601 - 609
  • [9] Cloning and expression of porcine recombinant soluble tumor necrosis factor receptor 1
    Boury, NM
    Bosworth, BT
    Stabel, TJ
    Kehrli, ME
    Taylor, MJ
    AMERICAN JOURNAL OF VETERINARY RESEARCH, 1998, 59 (10) : 1317 - 1322
  • [10] CHARACTERIZATION OF THE TUMOR NECROSIS FACTOR RECEPTOR IN HUMAN-PLACENTA
    EADES, DK
    CORNELIUS, P
    PEKALA, PH
    PLACENTA, 1988, 9 (03) : 247 - 251